LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mininggenetically-encoded small molecules (GEMs) from the biosphere, today announced the appointments of Martin Stahl
CAMBRIDGE, Mass. (BUSINESS WIRE) LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced the appointments of Martin Stahl, Ph.D., as chief scientific officer and Louis Plamondon, Ph.D., as executive.